AB Science S.A. (OTCMKTS:ABSCF) Short Interest Update

AB Science S.A. (OTCMKTS:ABSCF) was the recipient of a large decline in short interest in the month of April. As of April 15th, there was short interest totalling 400 shares, a decline of 95.0% from the March 31st total of 8,000 shares. Based on an average daily volume of 0 shares, the short-interest ratio is presently ∞ days.

AB Science Stock Performance

Shares of OTCMKTS:ABSCF opened at $2.70 on Friday. AB Science has a 12-month low of $2.55 and a 12-month high of $3.84. The company’s 50 day moving average price is $3.17 and its two-hundred day moving average price is $4.01.

AB Science Company Profile

AB Science SA, a pharmaceutical company, engages in the research, development, and marketing of protein kinase inhibitors for use in human and veterinary medicines. Its lead compound is the masitinib, a tyrosine kinase inhibitor that is in Phase III clinical trials for the treatment of prostate and pancreatic cancer, amyotrophic lateral sclerosis, multiple sclerosis, Alzheimer's, severe asthma, and mastocytosis diseases, as well as in Phase II clinical trial to treat Covid-19.